Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.83M Buy
+75,818
New +$1.98M ﹤0.01% 1375
2026
Q1
Sell
-22,428
Closed -$558K 3164
2025
Q4
$558K Buy
22,428
+5,545
+33% +$140K ﹤0.01% 2042
2025
Q3
$430K Sell
16,883
-4,578
-21% -$113K ﹤0.01% 2192
2025
Q2
$520K Buy
21,461
+2,806
+15% +$65.4K ﹤0.01% 2112
2025
Q1
$473K Buy
18,655
+3,912
+27% +$102K ﹤0.01% 2103
2024
Q4
$391K Buy
+14,743
New +$400K ﹤0.01% 2278

Other funds holding PFE

PEAK6's PFE Position: Q2 2026 in Review

PEAK6 opened a new position in Pfizer (PFE) in Q2 2026: 75,818 shares worth $1.83M. The stake represents ﹤0.01% of the portfolio and ranks #1375 among its holdings. This is a return to the name: PEAK6 previously reported a position in PFE as recently as Q4 2025.

PEAK6 first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • PEAK6 held 75,818 shares of Pfizer worth $1.83M as of Q2 2026.
  • Pfizer was a new PEAK6 position in Q2 2026.
  • Pfizer made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #1375 holding.
  • PEAK6 first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.